Cargando…
Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473643/ https://www.ncbi.nlm.nih.gov/pubmed/34586725 http://dx.doi.org/10.1002/ctm2.513 |
| _version_ | 1784575035197882368 |
|---|---|
| author | Zhu, Si‐Yuan Ma, Ding Ye, Fu‐Gui Shao, Zhi‐Ming Yu, Ke‐Da |
| author_facet | Zhu, Si‐Yuan Ma, Ding Ye, Fu‐Gui Shao, Zhi‐Ming Yu, Ke‐Da |
| author_sort | Zhu, Si‐Yuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8473643 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84736432021-10-01 Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial Zhu, Si‐Yuan Ma, Ding Ye, Fu‐Gui Shao, Zhi‐Ming Yu, Ke‐Da Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-09-26 /pmc/articles/PMC8473643/ /pubmed/34586725 http://dx.doi.org/10.1002/ctm2.513 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Zhu, Si‐Yuan Ma, Ding Ye, Fu‐Gui Shao, Zhi‐Ming Yu, Ke‐Da Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial |
| title | Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial |
| title_full | Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial |
| title_fullStr | Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial |
| title_full_unstemmed | Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial |
| title_short | Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial |
| title_sort | homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: a genomic landscape and biomarker assessment of the pattern trial |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473643/ https://www.ncbi.nlm.nih.gov/pubmed/34586725 http://dx.doi.org/10.1002/ctm2.513 |
| work_keys_str_mv | AT zhusiyuan homologousrecombinationdeficiencyandglycolysisrelatedpathwayinadjuvantchemotherapyfortriplenegativebreastcanceragenomiclandscapeandbiomarkerassessmentofthepatterntrial AT mading homologousrecombinationdeficiencyandglycolysisrelatedpathwayinadjuvantchemotherapyfortriplenegativebreastcanceragenomiclandscapeandbiomarkerassessmentofthepatterntrial AT yefugui homologousrecombinationdeficiencyandglycolysisrelatedpathwayinadjuvantchemotherapyfortriplenegativebreastcanceragenomiclandscapeandbiomarkerassessmentofthepatterntrial AT shaozhiming homologousrecombinationdeficiencyandglycolysisrelatedpathwayinadjuvantchemotherapyfortriplenegativebreastcanceragenomiclandscapeandbiomarkerassessmentofthepatterntrial AT yukeda homologousrecombinationdeficiencyandglycolysisrelatedpathwayinadjuvantchemotherapyfortriplenegativebreastcanceragenomiclandscapeandbiomarkerassessmentofthepatterntrial |